Benchmark Reiterates Buy on Aspen Aerogels, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Subash Chandra has reiterated a Buy rating on Aspen Aerogels (NYSE:ASPN) and maintained a $14 price target.
August 08, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Subash Chandra has reiterated a Buy rating on Aspen Aerogels and maintained a $14 price target.
The reiteration of a Buy rating and maintenance of a $14 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100